{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T21:10:30Z","timestamp":1661029830363},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13721-018-0167-z","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T08:44:23Z","timestamp":1524559463000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Probing the structural requirements for angiotensin II receptor: molecular modeling studies"],"prefix":"10.1007","volume":"7","author":[{"given":"M. C.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharm V.","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"167_CR1","first-page":"31","volume":"56","author":"GM Bahaa","year":"2006","unstructured":"Bahaa GM, Abdel AM, Hussein MA (2006) Synthesis of 1-acyl-2-alkylthio-1,2,4-triazolobenzimidazoles with antifungal, anti-inflammatory and analgesic effects. Acta Pharm 56:31\u201348","journal-title":"Acta Pharm"},{"issue":"3","key":"167_CR2","first-page":"225","volume":"42","author":"JB Bariwal","year":"2008","unstructured":"Bariwal JB, Shah AK, Kathiravan MK, Somani RS, Jagtap JR, Jain KS (2008) Synthesis and antiulcer activity of novel pyrimidylthiomethyl-and pyrimidyl sulfinyl methyl benzimidazoles as potential reversible proton pump inhibitors. Indian J Pharm Edu Res 42(3):225\u2013231","journal-title":"Indian J Pharm Edu Res"},{"issue":"22","key":"167_CR3","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1021\/jm00074a018","volume":"36","author":"CA Bernhart","year":"1993","unstructured":"Bernhart CA, Perreaut PM, Ferrari BP, Muneaux YA, Assens JL, Clement J, Haudricourt F, Muneaux CF, Taillades JE, Vignal MA, Gougat J, Giuraudou DR, Lacour CA, Roccon A, Cazaubon FC, Breliere JC, Fur GL, Nisato D (1993) A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists. J Med Chem 36(22):3371\u20133380","journal-title":"J Med Chem"},{"key":"167_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.molstruc.2014.10.036","volume":"1081","author":"KS Bhadoriya","year":"2015","unstructured":"Bhadoriya KS, Sharma MC, Jain S (2015a) Pharmacophore modeling and atom-based 3D-QSAR studies on amino derivatives of indole as potent isoprenylcysteine carboxyl methyltransferase (Icmt) inhibitors. J Mol Stru 1081:466\u2013476","journal-title":"J Mol Stru"},{"issue":"4","key":"167_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jtusci.2014.12.005","volume":"9","author":"KS Bhadoriya","year":"2015","unstructured":"Bhadoriya KS, Sharma MC, Jain S (2015b) 2,4-Dihydropyrano[2,3-c]pyrazole: discovery of new lead as through pharmacophore modelling, atom-based 3D-QSAR, virtual screening and docking strategies for improved anti-HIV-1 chemotherapy. J Taib Uni Sci 9(4):521\u2013530","journal-title":"J Taib Uni Sci"},{"key":"167_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0960-894X(01)81117-3","volume":"4","author":"P Buhl Mayer","year":"1994","unstructured":"Buhl Mayer P, Furet P, Criscione L, de Gaspro M, Schimidilin TS, LAttman R, Wood J (1994) Valsartan a potent orally active angiotensin II antagonist developed from a structurally new amino acid series. Biorg Med Chem Lett 4:29\u201334","journal-title":"Biorg Med Chem Lett"},{"key":"167_CR7","first-page":"35","volume":"27","author":"KUS Canan","year":"2003","unstructured":"Canan KUS, Nurten A (2003) Synthesis of some new benzimidazole carbamate derivatives for evaluation of antifungal activity. Turk J Chem 27:35\u201339","journal-title":"Turk J Chem"},{"key":"167_CR8","unstructured":"Chem-office (2004) version 8.0, has been supplied by Cambridge Software Company, 100, Cambridge Park Drive, Cambridge MA, 02140-2317, USA"},{"issue":"S1","key":"167_CR9","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1155\/2009\/604203","volume":"6","author":"YS Chhonker","year":"2009","unstructured":"Chhonker YS, Veenu B, Sr Hasim, Kaushik N, Kumar D, Kumar P (2009) Synthesis and pharmacological evaluation of some new 2-phenyl benzimidazoles derivatives and their Schiff bases. E-J Chem 6(S1):S342\u2013S346","journal-title":"E-J Chem"},{"issue":"4","key":"167_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00005344-199310000-00011","volume":"22","author":"JR Cockcroft","year":"1993","unstructured":"Cockcroft JR, Sciberras DG, Goldberg MR, Ritter JM (1993) Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J Cardiovasc Pharmacol 22(4):579\u2013584","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"167_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0223-5234(01)01313-7","volume":"37","author":"S Demirayak","year":"2002","unstructured":"Demirayak S, Abu Mohsen U, Ca\u011fri Karaburun A (2002) Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives. Eur J Med Chem 37(3):255\u2013260","journal-title":"Eur J Med Chem"},{"issue":"10\u201311","key":"167_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006a) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 20(10\u201311):647\u2013671","journal-title":"J Comput Aided Mol Des"},{"key":"167_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Rao SN (2006b) PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des 67:370\u2013372","journal-title":"Chem Biol Drug Des"},{"key":"167_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00005344-199000153-00001","volume":"15","author":"CM Ferrario","year":"1990","unstructured":"Ferrario CM (1990) The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol 15:S1","journal-title":"J Cardiovasc Pharmacol"},{"key":"167_CR15","first-page":"396","volume":"66","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Babu MA, Kaskhedikar SG (2004) VALSTAT: validation program for quantitative structure activity relationship studies. Indian J Pharm Sci 66:396\u2013402","journal-title":"Indian J Pharm Sci"},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0020-7519(01)00131-X","volume":"31","author":"P Kohler","year":"2001","unstructured":"Kohler P (2001) The biochemical basis of anthelmintic action and resistance. Int J Parasitol 31:336","journal-title":"Int J Parasitol"},{"key":"167_CR17","unstructured":"Ligprep 2.0 (2006) Schrodinger, LLC, New York"},{"issue":"15","key":"167_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","volume":"9","author":"R Morphy","year":"2004","unstructured":"Morphy R, Kay C, Rankovic Z (2004) From magic bullets to designed multiple ligands. Drug Discov Today 9(15):641\u2013651","journal-title":"Drug Discov Today"},{"issue":"6323","key":"167_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/351233a0","volume":"351","author":"TJ Murphy","year":"1991","unstructured":"Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351(6323):233\u2013236","journal-title":"Nature"},{"key":"167_CR20","volume-title":"The global burden of disease: in a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020","author":"CJL Murray","year":"1996","unstructured":"Murray CJL, Lopez AD (1996) The global burden of disease: in a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, 1st edn. Harvard University Press, Cambridge","edition":"1"},{"key":"167_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.farmac.2003.12.001","volume":"59","author":"W Nawrocka","year":"2004","unstructured":"Nawrocka W, Sztuba B, Kowalska MW, Liszkiewicz H, Wietrzyk J, Nasulewicz A, Pe\u0142czynska M, Opolski A (2004) Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives. IL Farmaco 59:83\u201391","journal-title":"IL Farmaco"},{"issue":"1","key":"167_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1586\/14779072.1.1.51","volume":"1","author":"K Norris","year":"2003","unstructured":"Norris K, Vaughn C (2003) The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther 1(1):51\u201363","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"167_CR23","unstructured":"O\u2019Neil MJ, Smith M, Heckelman (2001) The Merck Index. 13th edn. Merck & Co Inc. p 1785, 10074"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1021\/jm00136a001","volume":"24","author":"MA Ondetti","year":"1981","unstructured":"Ondetti MA, Cushman DW (1981) Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension. J Med Chem 24:355","journal-title":"J Med Chem"},{"key":"167_CR25","volume-title":"User manual","author":"Phase, version 2.0","year":"2006","unstructured":"Phase, version 2.0 (2006) User manual. Schr\u00f6dinger, LLC, New York"},{"key":"167_CR26","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1016\/j.bmc.2006.06.033","volume":"14","author":"MM Ramla","year":"2006","unstructured":"Ramla MM, Omar MA, EL-Khamry AM, EL-Diwani HI (2006) Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles. Bioorg Med Chem 14:7324\u20137332","journal-title":"Bioorg Med Chem"},{"issue":"6323","key":"167_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/351230a0","volume":"351","author":"K Sasaki","year":"1991","unstructured":"Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T (1991) Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351(6323):230\u2013233","journal-title":"Nature"},{"key":"167_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jtusci.2013.10.001","volume":"8","author":"MC Sharma","year":"2014","unstructured":"Sharma MC (2014) Structural requirements of N-aryl-oxazolidinone-5-carboxamide derivatives for anti-HIV protease activity using molecular modelling techniques. J Taib Univ Sci 8:111\u2013123","journal-title":"J Taib Univ Sci"},{"key":"167_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00044-013-0638-9","volume":"23","author":"MC Sharma","year":"2014","unstructured":"Sharma MC, Sharma S, Sharma P, Kumar A, Bhadoriya KS (2014a) QSAR and Pharmacophore approach on substituted imidazole derivatives as angiotensin II receptor antagonists. Med Chem Res 23:660\u2013681","journal-title":"Med Chem Res"},{"issue":"1","key":"167_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jtice.2013.08.002","volume":"45","author":"MC Sharma","year":"2014","unstructured":"Sharma MC, Sharma S, Sharma P, Kumar A, Bhadoriya KS (2014b) Structural insights for substituted acyl sulfonamides and acyl sulfamides derivatives of imidazole as angiotensin II receptor antagonists using molecular modeling approach. J Taiwan Inst Chem Eng 45(1)12\u201323","journal-title":"J Taiwan Inst Chem Eng"},{"key":"167_CR31","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1007\/s11771-015-2917-8","volume":"22","author":"MC Sharma","year":"2015","unstructured":"Sharma MC (2015a) Structural features of substituted triazole-linked chalcone derivatives as antimalarial activities against D10 strains of Plasmodium falciparum: a QSAR approach. J Cent South Univ 22:3738\u20133744","journal-title":"J Cent South Univ"},{"key":"167_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s13721-015-0088-z","volume":"4","author":"MC Sharma","year":"2015","unstructured":"Sharma MC (2015b) A comparative QSAR analysis of substituted imidazolones derivatives as angiotensin II AT1 receptor antagonists. Netw Model Anal Health Inform Bioinform 4:18","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"167_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13721-015-0100-7","volume":"4","author":"MC Sharma","year":"2015","unstructured":"Sharma MC (2015c) Predictive QSAR modeling of substituted Phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Netw Model Anal Health Inform Bioinform 4:26","journal-title":"Netw Model Anal Health Inform Bioinform"},{"issue":"2","key":"167_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12539-015-0005-2","volume":"7","author":"MC Sharma","year":"2015","unstructured":"Sharma MC (2015d) QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist. Interdiscip Sci Comput Life Sci 7(2):113\u2013128","journal-title":"Interdiscip Sci Comput Life Sci"},{"issue":"4","key":"167_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jtusci.2015.11.002","volume":"10","author":"MC Sharma","year":"2016","unstructured":"Sharma MC (2016a) 2D QSAR studies on a series of substituted purine derivatives inhibitory activity against c-Src tyrosine kinase. J Taib Uni Sci 10(4):563\u2013570","journal-title":"J Taib Uni Sci"},{"key":"167_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jtusci.2015.05.007","volume":"10","author":"MC Sharma","year":"2016","unstructured":"Sharma MC (2016b) QSAR studies of novel 1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acid derivatives and their precursors as antileukemic agents. J Taib Univ Sci 10:122\u2013130","journal-title":"J Taib Univ Sci"},{"key":"167_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13721-016-0139-0","volume":"5","author":"MC Sharma","year":"2016","unstructured":"Sharma MC (2016c) Rationalization of physicochemical characters and structural determinants of benzimidazole derivatives as casein kinase 2 inhibitors: Computational approach. Netw Model Anal Health Inform Bioinform 5:34","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"167_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13721-016-0116-7","volume":"5","author":"MC Sharma","year":"2016","unstructured":"Sharma MC (2016d) Computational design of novel renin inhibitors of indole-3-carboxamide derivatives through QSAR studies. Netw Model Anal Health Inform Bioinform 5:9","journal-title":"Netw Model Anal Health Inform Bioinform"},{"issue":"1","key":"167_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12539-015-0015-0","volume":"8","author":"MC Sharma","year":"2016","unstructured":"Sharma MC (2016e) Structural requirements of some 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide derivatives as poly (ADP-ribose) polymerase (PARP) for the treatment of cancer: QSAR approach. Interdiscip Sci Comput Life Sci 8(1):11\u201322","journal-title":"Interdiscip Sci Comput Life Sci"},{"issue":"3","key":"167_CR40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.53879\/id.54.03.10739","volume":"54","author":"MC Sharma","year":"2017","unstructured":"Sharma MC (2017) QSAR approach to the study of the EGFR tyrosine kinase inhibitors: thiazolyl-pyrazoline derivatives. Ind drug 54(3):5\u201312","journal-title":"Ind drug"},{"key":"167_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jtusci.2013.12.001","volume":"8","author":"MC Sharma","year":"2014","unstructured":"Sharma MC, Sharma S (2014a) Prediction of potent therapeutic targets of anticonvulsant ligands substituted 4, 6-dichloroindole-2-carboxylic acids as N-methyl-d-aspartate receptor: molecular modelling approach. J Taib Univ Sci 8:98\u2013110","journal-title":"J Taib Univ Sci"},{"key":"167_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/739646","author":"MC Sharma","year":"2014","unstructured":"Sharma MC, Sharma S (2014b) Molecular modeling studies of thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents. Int J Med Chem. https:\/\/doi.org\/10.1155\/2014\/739646","journal-title":"Int J Med Chem"},{"issue":"4","key":"167_CR43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12539-016-0176-5","volume":"8","author":"MC Sharma","year":"2016","unstructured":"Sharma MC, Sharma S (2016) Investigation on quantitative structure activity relationships of a series of inducible nitric oxide. Interdiscip Sci Comput Life Sci 8(4):346\u2013351","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"167_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/427181","author":"MC Sharma","year":"2013","unstructured":"Sharma MC, Kohli DV, Sharma S (2013) Molecular modeling studies of substituted 2, 4, 5-trisubstituted triazolinones aryl and nonaryl derivatives as angiotensin II AT1 receptor antagonists. J Chem. https:\/\/doi.org\/10.1155\/2013\/427181","journal-title":"J Chem"},{"key":"167_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s13721-016-0120-y","volume":"5","author":"MC Sharma","year":"2016","unstructured":"Sharma MC, Sharma S, Sharma S (2016a) Computational study of diarylcyclopentene derivatives as selective prostaglandin EP1 receptor antagonist: QSAR approach. Netw Model Anal Health Inform Bioinform 5:14","journal-title":"Netw Model Anal Health Inform Bioinform"},{"issue":"1","key":"167_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtusci.2015.06.003","volume":"10","author":"MC Sharma","year":"2016","unstructured":"Sharma MC, Sharma S, Bhadoriya KS (2016b) QSAR studies on pyrazole-4-carboxamide derivatives as aurora a kinase inhibitors. J Taib Univ Sci 10(1):107\u2013114","journal-title":"J Taib Univ Sci"},{"issue":"4","key":"167_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF00124500","volume":"10","author":"CA Sotriffer","year":"1996","unstructured":"Sotriffer CA, Winger RH, Liedl KR, Rode BM, Varga JM (1996) Comparative docking studies on ligand binding to the multispecific antibodies IgE-La2 and IgE-Lb4. J Comput Aided Mol Des 10(4):305\u2013320","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"167_CR48","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/BF01919842","volume":"32","author":"VJ Theodorides","year":"1976","unstructured":"Theodorides VJ, Gyurik RJ, Kingsbury WD, Parish RC (1976) Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia 32(6):702\u2013703","journal-title":"Experientia"},{"issue":"14","key":"167_CR49","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1021\/jm060338p","volume":"49","author":"T Tuccinardi","year":"2006","unstructured":"Tuccinardi T, Calderone V, Rapposelli S, Martinelli A (2006) Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis. J Med Chem 49(14):4305\u20134316","journal-title":"J Med Chem"},{"issue":"2A","key":"167_CR50","doi-asserted-by":"publisher","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","volume":"89","author":"T Unger","year":"2002","unstructured":"Unger T (2002) The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89(2A):3A\u20139A","journal-title":"Am J Cardiol"},{"issue":"5","key":"167_CR51","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ejmech.2007.06.013","volume":"43","author":"R Vinod Kumar","year":"2008","unstructured":"Vinod Kumar R, Vaidya SD, Siva Kumar BV, Bhise UN, Bhirud SB, Mashelkar UC (2008) Synthesis, anti-bacterial, anti-asthmatic and anti-diabetic activities of novel N-substituted-2-(4-phenylethynyl-phenyl)-1H-benzimidazoles and N-substituted 2[4-(4,4-dimethyl-thiochroman-6-yl-ethynyl)-phenyl)-1H-benzimidazoles. Eur J Med Chem 43(5):986\u2013995","journal-title":"Eur J Med Chem"},{"key":"167_CR52","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/00004872-200308000-00001","volume":"21","author":"M Volpe","year":"2003","unstructured":"Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A (2003) Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease. J Hypertens 21:1429\u20131443","journal-title":"J Hypertens"},{"issue":"2","key":"167_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3317\/jraas.2003.015","volume":"4","author":"MA Weber","year":"2003","unstructured":"Weber MA (2003) Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold? J. Renin Angiotensin Aldosterone Syst 4(2):62\u201373","journal-title":"J. Renin Angiotensin Aldosterone Syst"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-018-0167-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0167-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0167-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T20:32:00Z","timestamp":1661027520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-018-0167-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s13721-018-0167-z","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"4 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}